TNFRSF10B and neoplasm: To enhance tumor targeting and therapeutic efficacy, a multifunctional nanoparticle system was developed by conjugating Ce6 to Bifidobacterium bifidum, followed by attachment of an anti-DR5 antibody, resulting in the construct Ce6–B. bifidum–anti-DR5 Ab.